Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke

Summary

The investigators conduct this study to investigate whether oral administration of Dimethyl Fumarate, a Food and Drug Administration-approved drug for multiple sclerosis, is safe and effective in in alleviating neurologic deficits in patients with Acute Ischemic Stroke.

Timeline

Start

2021-12-01

Primary completion

2023-02-08

Completion

2023-02-28

Drugs

Indications